AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-13142215_ITM" title="Facts and information about US FDA IND approval triggers a further A$2M investment in Xenome.">US FDA IND approval triggers a further A$2M investment in Xenome.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
US FDA IND approval triggers a further A$2M investment in Xenome.
(From Chemical Business NewsBase - Australasian Biotechnology)
The US Food and Drug Administration's Center for Drug Evaluation and Research had approved Xenome Ltd's Investigational New Drug submission for the new pain drug, Xen2174. The approval stimulated another tranche investment of A$2 M from Queensland BioCapital Fund. The approval would also allow the company to start a human ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Hatteras BioCapital Announces Investment by Golden LEAF in HBM BioCapital...
- Press release article from: PR Newswire May 20, 2004 700+ words
...USD), LP through Hatteras BioCapital Fund, LP. HBM BioCapital is a later...General Partner of the Hatteras BioCapital Fund, LP (formerly known as BioVista Fund I, LP). The Hatteras BioCapital Fund, LP is a single-purpose entity...
- Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland...
- Press release article from: PR Newswire November 27, 2007 700+ words
BRISBANE, Australia, Nov. 27 /PRNewswire/ -- Xenome Ltd, a specialist biopharmaceutical company developing novel peptide drugs, announced today that it has successfully raised US$10M of equity finance. The syndicated funding round includes continuing support from Xenome's major investor, Queensland
- Biomira files investigational new drug application for PX-478, a novel...
- Press release article from: PR Newswire July 3, 2007 700+ words
...announced that it has submitted an investigational new drug (IND) application to the...and PX-866; the filing of an investigational new drug application for PX-478 and...and PX-866; the filing of an investigational new drug application for PX-478 and...
- US DOD: DOD, RAND releases policy review on use of investigational new drugs...
- Press release article from: M2 Presswire April 16, 1999 700+ words
...releases policy review on use of investigational new drugs during Gulf War (C)1994...policy review concerning the use of investigational new drugs (INDs) during the Gulf War...Some veterans believe the use of investigational new drugs may have caused their illnesses...
- Quigley to Commence Human Testing of Its QR-333 Topical Diabetic Peripheral...
- Press release article from: PR Newswire April 10, 2006 700+ words
...commencing human studies on its investigational new drug, QR-333. Patient screening...pharmacokinetics of Quigley's Investigational New Drug, QR-333. A Phase II(b...agency will allow the aforementioned Investigational New Drug to be marketed. Furthermore...
- investigational new drug (IND)
- Reference information from: The Mosby Medical Encyclopedia October 1, 1996 700+ words
The Mosby Medical Encyclopedia 10-01-1996 investigational new drug (IND), a drug not yet approved by the...see its safety and effectiveness. The use of an investigational new drug in human subjects requires approval by the...
- Immunomedics files Investigational New Drug Application with FDA for infectious...
- Press release article from: PR Newswire June 29, 1990 700+ words
IMMUNOMEDICS FILES INVESTIGATIONAL NEW DRUG APPLICATION WITH FDA FOR INFECTIOUS DISEASE IMAGING...Inc. (NASDAQ: IMMU) announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug...
- Immunomedics files investigational new drug application with FDA for cancer...
- Press release article from: PR Newswire May 3, 1990 700+ words
IMMUNOMEDICS FILES INVESTIGATIONAL NEW DRUG APPLICATION WITH FDA FOR CANCER IMAGING AGENT WARREN...NASDAQ: IMMU) announced today that it has filed an investigational new drug (IND) application with the U.S. Food and Drug...